Literature DB >> 15623848

Antibiotic lock technique: a review of the literature.

Marisel Segarra-Newnham1, Ellen M Martin-Cooper.   

Abstract

OBJECTIVE: To review the literature on the use of the antibiotic lock technique (ALT) as a treatment option for patients with highly needed catheters. DATA SOURCES: MEDLINE and International Pharmaceutical Abstracts were searched (1980-August 2004). Search terms included antibiotic lock, catheter infection, and topical treatment. STUDY SELECTION AND DATA EXTRACTION: Articles describing use of ALT in the treatment of catheter infections in humans and studies evaluating in vitro stability of antibiotics were included. DATA SYNTHESIS: ALT has been used in patients with highly needed catheters, usually for parenteral nutrition, cancer chemotherapy, or dialysis. Catheters are considered highly needed when removal is not feasible or desirable due to lack of alternative injection sites for required therapy. Success rates in saving the infected catheter have been variable and may depend on the infecting organism. In addition, there are conflicting data in terms of compatibility of antibiotics with heparin solutions.
CONCLUSIONS: Consensus appears to be that the ALT can be tried for patients with highly needed catheters when infection with coagulase-negative staphylococci is documented and no systemic signs of sepsis, such as hypotension, are evident. Most of these patients are likely to need systemic therapy as well. Infection of the catheter associated with systemic gram-negative bacteremia or fungemia will most likely require removal of the catheter to prevent systemic complications. Additional research with the ALT is warranted given unanswered questions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623848     DOI: 10.1345/aph.1E316

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  13 in total

1.  Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection.

Authors:  F Bartalesi; S Veloci; F Baragli; E Mantengoli; S Guidi; A M Bartolesi; R Mannino; P Pecile; A Bartoloni
Journal:  Infection       Date:  2011-10-18       Impact factor: 3.553

2.  A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device.

Authors:  Simone Cesaro; Mara Cavaliere; Monica Spiller; Lucia Rossi; Laura Magagna; Patrizia Gavin; Michela Bonetto; Modesto Carli
Journal:  Support Care Cancer       Date:  2006-07-01       Impact factor: 3.603

3.  Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.

Authors:  Andrew D G Van Praagh; Tongchuan Li; Shuxin Zhang; Anu Arya; Liping Chen; Xi-Xian Zhang; Shellie Bertolami; Lawrence I Mortin
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 4.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

5.  Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.

Authors:  Issam Raad; Hend Hanna; Tanya Dvorak; Gassan Chaiban; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

6.  Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms.

Authors:  Brian M Peters; Raven M Ward; Hallie S Rane; Samuel A Lee; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 7.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.

Authors:  Ruth A Reitzel; Joel Rosenblatt; Cheryl Hirsh-Ginsberg; Kimberly Murray; Anne-Marie Chaftari; Ray Hachem; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

9.  Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material.

Authors:  Matthew P Lungren; Diana Christensen; Ravi Kankotia; Irene Falk; Ben E Paxton; Charles Y Kim
Journal:  Bacteriophage       Date:  2013-10-24

10.  Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.

Authors:  Hubertine M E Willems; Jeremy S Stultz; Molly E Coltrane; Jabez P Fortwendel; Brian M Peters
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.